Volume 60, Issue 2, Pages (August 2001)

Slides:



Advertisements
Similar presentations
Fig. 2. Effects of lobeglitazone on profibrotic gene expression in kidneys of unilateral ureteral obstruction (UUO) mice. (A) Representative Western blot.
Advertisements

Volume 74, Issue 3, Pages (August 2008)
Volume 77, Issue 6, Pages (March 2010)
Volume 78, Issue 3, Pages (August 2010)
Plasmin is not protective in experimental renal interstitial fibrosis1
Inhibition of ILK by QLT-0267 suppresses type I and type III collagen expression and ameliorates interstitial collagen deposition and renal fibrosis after.
Volume 76, Issue 1, Pages (July 2009)
Volume 82, Issue 6, Pages (September 2012)
David J. Nikolic-Paterson, Shuang Wang, Hui Yao Lan 
Volume 84, Issue 2, Pages (August 2013)
Volume 68, Issue 6, Pages (December 2005)
IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy  J.-A. Moon,
Volume 86, Issue 3, Pages (September 2014)
Volume 69, Issue 10, Pages (May 2006)
Volume 88, Issue 3, Pages (September 2015)
Volume 74, Issue 3, Pages (August 2008)
John Keeling, Guillermo A. Herrera  Kidney International 
Volume 84, Issue 1, Pages (July 2013)
Mast cells decrease renal fibrosis in unilateral ureteral obstruction
Volume 61, Issue 1, Pages (January 2002)
Volume 67, Issue 4, Pages (April 2005)
Volume 58, Issue 2, Pages (August 2000)
Relaxin in cardiovascular and renal disease
Volume 80, Issue 10, Pages (November 2011)
Volume 61, Issue 5, Pages (May 2002)
Heterozygous disruption of activin receptor–like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy  José.
Izabella Z.A. Pawluczyk, Samita R. Patel, Kevin P.G. Harris 
Angiotensin converting enzyme inhibitor but not angiotensin receptor blockade or statin ameliorates murine adriamycin nephropathy  S.C.W. Tang, J.C.K.
Volume 81, Issue 12, Pages (June 2012)
Volume 84, Issue 2, Pages (August 2013)
Volume 84, Issue 5, Pages (November 2013)
The renal lesions that develop in neonatal mice during angiotensin inhibition mimic obstructive nephropathy  Yoichi Miyazaki, Shinya Tsuchida, Agnes Fogo,
Volume 81, Issue 5, Pages (March 2012)
Hepatocyte growth factor suppresses interstitial fibrosis in a mouse model of obstructive nephropathy  Shinya Mizuno, Kunio Matsumoto, Toshikazu Nakamura 
Activation of Erk1/2 and Akt following unilateral ureteral obstruction
Volume 57, Issue 3, Pages (March 2000)
1,25-dihydroxyvitamin D3 inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression  Yingjian Li, Bradley C.
Hypoxia promotes fibrogenesis in human renal fibroblasts
Volume 65, Issue 6, Pages (June 2004)
Volume 92, Issue 3, Pages (September 2017)
P. Harding, L. Balasubramanian, J. Swegan, A. Stevens, W.F. Glass 
Izabella Z.A. Pawluczyk, Kevin P.G. Harris  Kidney International 
Volume 76, Issue 5, Pages (September 2009)
Volume 55, Issue 3, Pages (March 1999)
Caspase-3 and apoptosis in experimental chronic renal scarring
Volume 59, Issue 2, Pages (February 2001)
Volume 63, Issue 6, Pages (June 2003)
Effect of nitric oxide modulation on TGF-β1 and matrix proteins in chronic cyclosporine nephrotoxicity  Fuad S. Shihab, Hong Yi, William M. Bennett, Takeshi.
Volume 85, Issue 2, Pages (January 2014)
Volume 75, Issue 6, Pages (March 2009)
Volume 58, Issue 6, Pages (December 2000)
Volume 82, Issue 2, Pages (July 2012)
Volume 66, Issue 5, Pages (November 2004)
Izabella Z.A. Pawluczyk, Samita R. Patel, Kevin P.G. Harris 
Volume 56, Issue 2, Pages (August 1999)
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
M.-J. Wu, M.-C. Wen, Y.-T. Chiu, Y.-Y. Chiou, K.-H. Shu, M.-J. Tang 
Volume 67, Issue 6, Pages (June 2005)
Robert L. Chevalier, Barbara A. Thornhill, Alice Y. Chang 
CD4+ T cells: a potential player in renal fibrosis
Kaihui Liang, Nosratola D. Vaziri  Kidney International 
Volume 54, Issue 1, Pages (July 1998)
Volume 60, Issue 5, Pages (November 2001)
Volume 58, Issue 5, Pages (November 2000)
Volume 76, Issue 8, Pages (October 2009)
Volume 59, Issue 6, Pages (June 2001)
Jens Gaedeke, Nancy A. Noble, Wayne A. Border  Kidney International 
The Relaxin Gene Knockout Mouse: A Model of Progressive Scleroderma
Volume 21, Issue 2, Pages (February 2013)
Plasmin is not protective in experimental renal interstitial fibrosis1
Presentation transcript:

Volume 60, Issue 2, Pages 587-596 (August 2001) PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction  Takashi Oda, Young Ok Jung, Heung Soo Kim, Xiaohe Cai, Jesús M. López-Guisa, Yukiko Ikeda, Allison A. Eddy  Kidney International  Volume 60, Issue 2, Pages 587-596 (August 2001) DOI: 10.1046/j.1523-1755.2001.030002587.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Sirius red staining of interstitial collagen fibrils. (A–D) These are from plasminogen-activator inhibitor-1 (PAI-1) wild-type (+/+) mice that were sham-operated (sham), and after 3, 7 and 14 days (3D, 7D, and 14D) of unilateral ureteral obstruction (UUO), respectively. (E–H) These are -/- sham, 3D, 7D, and 14D UUO, respectively (×400). (I) Data are mean ± 1 SD % of the interstitial area stained. Symbols are: (□) ++ mice; (▪) -/- mice; *P < 0.05 compared with sham controls of the same genotype. Kidney International 2001 60, 587-596DOI: (10.1046/j.1523-1755.2001.030002587.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Total kidney collagen in (□) +/+ and (▪) -/- mice. Results are mean ± 1 SD. *P < 0.05 compared with sham controls of the same genotype. Kidney International 2001 60, 587-596DOI: (10.1046/j.1523-1755.2001.030002587.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 (A) Representative Northern blot autoradiograph of renal mRNA levels for plasminogen-activator inhibitor-1 (PAI-1), tissue-type plasminogen activator (tPA), urokinase-type plasminogen activator (uPA), and α2-antiplasmin (α2-AP). The graph shows the results of PAI-1 Northern blotting when RNA from each experimental animal was loaded into separate wells, expressed in arbitrary units as mean ± 1 SD (B). No PAI-1 mRNA band was detected in the kidneys of the -/- mice. *P < 0.05 compared with sham controls of the same genotype. Similar analyses (data not shown) found a significant 50% increase in uPA only at 7D after UUO and a 300 to 400% increase in tPA at 3D, 7D, and 14D after UUO compared with sham kidneys, and a significant 20 to 60% decrease in α2-AP at all time points. There were no differences in the tPA, uPA, and α2-AP responses between the +/+ and -/- mice. Kidney International 2001 60, 587-596DOI: (10.1046/j.1523-1755.2001.030002587.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 4 PAI-1 Western blotting of kidney supernatants identified a definite PAI-1 protein band (53 kD) only in the +/+ mice at 7D and 14D. Amido black staining shown in the lower portion of this figure confirmed equivalency of protein loading and transfer. Kidney International 2001 60, 587-596DOI: (10.1046/j.1523-1755.2001.030002587.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 5 (A) Representative plasminogen gel zymogram. The graph illustrates the mean relative activity after analysis of each experimental animal (B). Symbols are: (□) ++ mice; (▪) -/- mice; *P < 0.05 compared with sham controls of the same genotype. Abbreviation is: H.uPA, human urokinase-type plasminogen activator. Kidney International 2001 60, 587-596DOI: (10.1046/j.1523-1755.2001.030002587.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 6 Renal plasmin activity expressed as mean relative activity ± 1 SD. Symbols are: (□) ++ mice; (▪) -/- mice; *P < 0.05 compared with sham controls of the same genotype. Kidney International 2001 60, 587-596DOI: (10.1046/j.1523-1755.2001.030002587.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 7 (A) Representative Northern blot autoradiograph of renal mRNA levels for α1(I) procollagen (Col I) and α1(III) procollagen (Col III) and transforming growth factor-β (TGF-β). The graphs show the results when RNA from each experimental animal was loaded into separate wells and probed, expressed in arbitrary units as mean ± 1 SD (B). Symbols are: (□) ++ mice; (▪) -/- mice; *P < 0.05 compared with sham controls of the same genotype. Kidney International 2001 60, 587-596DOI: (10.1046/j.1523-1755.2001.030002587.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 8 F4/80+ interstitial macrophages. (A–D) These are +/+ sham, 3D, 7D, and 14D UUO, respectively. (E–H) These are -/- sham, 3D, 7D, and 14D UUO, respectively (×400). (I) The graph is % interstitial area stained expressed as mean ± 1 SD. *P < 0.05 compared with sham controls of the same genotype. Kidney International 2001 60, 587-596DOI: (10.1046/j.1523-1755.2001.030002587.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 9 α-Smooth muscle actin (α-SMA)-positive interstitial myofibroblasts. (A–D) These are +/+ sham, 3D, 7D, and 14D UUO respectively. (E–H) These are -/- sham, 3D, 7D, and 14D UUO, respectively. (I) The graph is % interstitial area stained expressed as mean ± 1 SD. *P < 0.05 compared with sham controls of the same genotype (×400). Kidney International 2001 60, 587-596DOI: (10.1046/j.1523-1755.2001.030002587.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 10 Murine macrophage chemotactic response to murine PAI-1 and uPA. Symbols are: (♦) PAI-1; (▪) uPA; (#) PAI-1 + urokinase receptor macrophages (uPAR -/- Mφ) Results are the mean values of five separate experiments. The (+) control line indicates the mean number of macrophages recruited in response to 10−8 mol/L f-met-leu-phe (42 ± 7 in 5 experiments). The (-) control line indicates the mean number of macrophages recruited in response to media alone (18 ± 6 in 5 experiments). In three separate experiments using peritoneal Mφ from mice with a genetic deficiency of the urokinase receptor (uPAR-/-), a similar chemotactic response to PAI-1 was observed (# linked with a broken line illustrate mean values). *P < 0.05 compared with the negative control. Kidney International 2001 60, 587-596DOI: (10.1046/j.1523-1755.2001.030002587.x) Copyright © 2001 International Society of Nephrology Terms and Conditions